OBJECTIVES: Increasing evidence suggests that depression is a risk factor for cognitive impairment, but it is unclear if this is true among the oldest old. We determined whether elevated depressive symptoms predicted 5-year incident mild cognitive impairment (MCI) or dementia, and neuropsychological test performance among oldest-old women. DESIGN: Prospective. SETTING: Three study sites. PARTICIPANTS: 302 women ≥85 years (mean, 87 ± 2). MEASUREMENTS: Depressive symptoms were measured with the 15-item Geriatric Depression Scale (GDS); scores of 6 or more indicated elevated symptoms. Five years later, participants completed neuropsychological testing and clinical cognitive status was adjudicated. RESULTS: In analyses of MCI versus normal cognition, 70% of women with GDS score 6 or more at baseline developed MCI versus 37% with GDS score less than 6. After adjustment for age, education, alcohol, and benzodiazepine use, and study site, GDS score 6 or more remained independently associated with much greater likelihood of developing MCI (multivariable odds ratio [MOR] = 3.71, 95% confidence interval (CI): 1.30-10.59). In analyses of dementia versus normal cognition, 65% of women with GDS score 6 or more developed dementia compared with 37% of those with GDS score less than 6 (MOR = 3.15, 95% CI: 1.03-9.65). Only 19% of women with GDS score 6 or more had normal cognitive status 5 years later, compared with 46% of those with GDS score less than 6 (MOR = 0.28, 95% CI: 0.11-0.73). Women with elevated depressive symptoms had worse scores on tests of global cognition and working memory. CONCLUSION: Elevated depressive symptoms are an important risk factor for cognitive disorders and lower cognitive performance among women living to their ninth and tenth decades.
OBJECTIVES: Increasing evidence suggests that depression is a risk factor for cognitive impairment, but it is unclear if this is true among the oldest old. We determined whether elevated depressive symptoms predicted 5-year incident mild cognitive impairment (MCI) or dementia, and neuropsychological test performance among oldest-old women. DESIGN: Prospective. SETTING: Three study sites. PARTICIPANTS: 302 women ≥85 years (mean, 87 ± 2). MEASUREMENTS: Depressive symptoms were measured with the 15-item Geriatric Depression Scale (GDS); scores of 6 or more indicated elevated symptoms. Five years later, participants completed neuropsychological testing and clinical cognitive status was adjudicated. RESULTS: In analyses of MCI versus normal cognition, 70% of women with GDS score 6 or more at baseline developed MCI versus 37% with GDS score less than 6. After adjustment for age, education, alcohol, and benzodiazepine use, and study site, GDS score 6 or more remained independently associated with much greater likelihood of developing MCI (multivariable odds ratio [MOR] = 3.71, 95% confidence interval (CI): 1.30-10.59). In analyses of dementia versus normal cognition, 65% of women with GDS score 6 or more developed dementia compared with 37% of those with GDS score less than 6 (MOR = 3.15, 95% CI: 1.03-9.65). Only 19% of women with GDS score 6 or more had normal cognitive status 5 years later, compared with 46% of those with GDS score less than 6 (MOR = 0.28, 95% CI: 0.11-0.73). Women with elevated depressive symptoms had worse scores on tests of global cognition and working memory. CONCLUSION:Elevated depressive symptoms are an important risk factor for cognitive disorders and lower cognitive performance among women living to their ninth and tenth decades.
Authors: Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky Journal: JAMA Date: 2002-09-25 Impact factor: 56.272
Authors: Brenda W J H Penninx; Stephen B Kritchevsky; Kristine Yaffe; Anne B Newman; Eleanor M Simonsick; Susan Rubin; Luigi Ferrucci; Tamara Harris; Marco Pahor Journal: Biol Psychiatry Date: 2003-09-01 Impact factor: 13.382
Authors: Meryl A Butters; Ellen M Whyte; Robert D Nebes; Amy E Begley; Mary Amanda Dew; Benoit H Mulsant; Michelle D Zmuda; Rishi Bhalla; Carolyn Cidis Meltzer; Bruce G Pollock; Charles F Reynolds; James T Becker Journal: Arch Gen Psychiatry Date: 2004-06
Authors: Alan J Thomas; John T O'Brien; Sue Davis; Clive Ballard; Robert Barber; Rajesh N Kalaria; Robert H Perry Journal: Arch Gen Psychiatry Date: 2002-09
Authors: Jennifer B Levin; Michelle E Aebi; Kathleen A Smyth; Curtis Tatsuoka; Johnny Sams; Thomas Scheidemantel; Martha Sajatovic Journal: Am J Geriatr Psychiatry Date: 2015-04-22 Impact factor: 4.105
Authors: Meghan K Mattos; Beth E Snitz; Jennifer H Lingler; Lora E Burke; Lorraine M Novosel; Susan M Sereika Journal: J Rural Health Date: 2016-08-10 Impact factor: 4.333
Authors: M W Williams; A M Kueider; N O Dmitrieva; J J Manly; C F Pieper; S P Verney; L E Gibbons Journal: Int J Geriatr Psychiatry Date: 2016-08-09 Impact factor: 3.485
Authors: Breno S Diniz; Meryl A Butters; Steven M Albert; Mary Amanda Dew; Charles F Reynolds Journal: Br J Psychiatry Date: 2013-05 Impact factor: 9.319
Authors: Sid E O'Bryant; Leigh Johnson; Joan Reisch; Melissa Edwards; James Hall; Robert Barber; Michael D Devous; Donald Royall; Meharvan Singh Journal: Alzheimers Dement Date: 2013-05-02 Impact factor: 21.566